Ischemic stroke: clinical guidelines and practical aspects

Time codes:
  • 00:01:00

    The global problem of stroke

  • 00:03:19

    General principles of managing patients with stroke

  • 00:08:20

    Stroke assessment scales

  • 00:13:09

    Attitudes towards neuroprotective therapy in the world

  • 00:19:24

    The ideal neuroprotector: "What is it?"

Lecturers: Evgeniya Viktorovna Ekusheva, MD, Professor, Head of the Department of Nervous System Diseases and Neurorehabilitation, Academy of Postgraduate Education, Federal Scientific and Clinical Center of the Federal Medical and Biological Agency of Russia; Ivan Aleksandrovich Shchukin, MD, PhD, Associate Professor, Department of Neurology, Neurosurgery, and Medical Genetics, Faculty of Medicine, N.I. Pirogov Russian National Research Medical University

Announcement:

Leading Russian neurologists—Professor E.V. Ekusheva and Associate Professor I.A. Shchukin —are conducting an open professional dialogue dedicated to the key issues in managing patients with ischemic stroke.

Key topics for discussion:

  •         General principles of managing patients with stroke: Modern standards of diagnosis and treatment at different stages of medical care.
  •         Practical application of scales: which scales for assessing stroke severity and prognosis (NIHSS, Rankin) are the most clinically significant and how to use them for decision-making.
  •         Neuroprotective Therapy: Global Context and Evidence Base. A Critical Analysis of International Approaches and Research.
  •         Portrait of an ideal neuroprotector: what properties should a drug have in terms of the pathogenesis of the ischemic cascade?
  •         Use of Mexidol® in the acute phase of stroke and during recovery: data review, mechanism of action, and its role in combination therapy according to research and clinical guidelines.

This dialogue is a distillation of expert opinion, allowing us to look beyond the formal texts of recommendations and understand the logic behind the decisions made by leading experts.

Why is it important to watch this dialogue?
You will witness a dialogue between clinical neurology experts. This video lecture format allows you to understand recommendations and practical algorithms, and can also help you make the right choice when using neuroprotective medications in real-world clinical practice.

THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.

Source of photos and images Shutterstock.com